Efficacy and Safety Study of MYOBLOC® Followed by Open-Label Multiple-Treatment With MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adult Subjects (MYSTICOL)

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2015 by US WorldMeds LLC
Information provided by (Responsible Party):
US WorldMeds LLC
ClinicalTrials.gov Identifier:
First received: November 14, 2013
Last updated: October 2, 2015
Last verified: October 2015